Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan P Sleeman

Showing results (21-30 of 83) with videos related to

Pageof 9
Sort By:
Oncogene|August 3, 2004
Differential immunization identifies PHB1/PHB2 as blood-borne tumor antigensJörg Mengwasser, Angela Piau, Peter Schlag, et al.
Cancers|September 24, 2020
RASSF1A Suppresses Estrogen-Dependent Breast Cancer Cell Growth through Inhibition of the Yes-Associated Protein 1 (YAP1), Inhibition of the Forkhead Box Protein M1 (FOXM1), and Activation of Forkhead Box Transcription Factor 3A (FOXO3A)Sven Roßwag, Gitta Thiede, Jonathan P Sleeman, et al.
Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire|June 3, 2016
Footprintless disruption of prosurvival genes in aneuploid cancer cells using CRISPR/Cas9 technologyJustyna M Krachulec, Georg Sedlmeier, Wilko Thiele, et al.
International Journal of Cancer|August 22, 2012
Tumor-initiating properties of breast cancer and melanoma cells in vivo are not invariably reflected by spheroid formation in vitro, but can be increased by long-term culturing as adherent monolayersVanessa Kuch, Caroline Schreiber, Wilko Thiele, et al.
Chembiochem : a European Journal of Chemical Biology|December 14, 2004
Aristoforin, a novel stable derivative of hyperforin, is a potent anticancer agentMichael Gartner, Thomas Müller, Jan C Simon, et al.
Genes & Development|December 5, 2002
CD44 is required for two consecutive steps in HGF/c-Met signalingVéronique Orian-Rousseau, Linfeng Chen, Jonathan P Sleeman, et al.
Frontiers in Bioengineering and Biotechnology|April 10, 2018
Effect of Co-presentation of Adhesive Ligands and Short Hyaluronan on Lymphendothelial CellsChristiane H Antoni, Yvonne McDuffie, Jochen Bauer, et al.
Clinical & Experimental Metastasis|November 6, 2007
Pre-EMTing metastasis? Recapitulation of morphogenetic processes in cancerGeert Berx, Eric Raspé, Gerhard Christofori, et al.
Oncotarget|October 27, 2017
Proteasome inhibitors prevent bi-directional HER2/estrogen-receptor cross-talk leading to cell death in endocrine and lapatinib-resistant HER2+/ER+ breast cancer cellsSonja Thaler, Marcus Schmidt, Sven Roβwag, et al.
Biotechniques|June 2, 2009
Cell cycle quiescence can suppress transcription from an ecdysone receptor-based inducible promoter in mammalian cellsSabine Wallbaum, Nicole Grau, Anja Schmid, et al.
Pageof 9

Showing results (21-30 of 83) with videos related to

Sort By:
Pageof 9
Oncogene|August 3, 2004
Differential immunization identifies PHB1/PHB2 as blood-borne tumor antigensJörg Mengwasser, Angela Piau, Peter Schlag, et al.
Cancers|September 24, 2020
RASSF1A Suppresses Estrogen-Dependent Breast Cancer Cell Growth through Inhibition of the Yes-Associated Protein 1 (YAP1), Inhibition of the Forkhead Box Protein M1 (FOXM1), and Activation of Forkhead Box Transcription Factor 3A (FOXO3A)Sven Roßwag, Gitta Thiede, Jonathan P Sleeman, et al.
Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire|June 3, 2016
Footprintless disruption of prosurvival genes in aneuploid cancer cells using CRISPR/Cas9 technologyJustyna M Krachulec, Georg Sedlmeier, Wilko Thiele, et al.
International Journal of Cancer|August 22, 2012
Tumor-initiating properties of breast cancer and melanoma cells in vivo are not invariably reflected by spheroid formation in vitro, but can be increased by long-term culturing as adherent monolayersVanessa Kuch, Caroline Schreiber, Wilko Thiele, et al.
Chembiochem : a European Journal of Chemical Biology|December 14, 2004
Aristoforin, a novel stable derivative of hyperforin, is a potent anticancer agentMichael Gartner, Thomas Müller, Jan C Simon, et al.
Genes & Development|December 5, 2002
CD44 is required for two consecutive steps in HGF/c-Met signalingVéronique Orian-Rousseau, Linfeng Chen, Jonathan P Sleeman, et al.
Frontiers in Bioengineering and Biotechnology|April 10, 2018
Effect of Co-presentation of Adhesive Ligands and Short Hyaluronan on Lymphendothelial CellsChristiane H Antoni, Yvonne McDuffie, Jochen Bauer, et al.
Clinical & Experimental Metastasis|November 6, 2007
Pre-EMTing metastasis? Recapitulation of morphogenetic processes in cancerGeert Berx, Eric Raspé, Gerhard Christofori, et al.
Oncotarget|October 27, 2017
Proteasome inhibitors prevent bi-directional HER2/estrogen-receptor cross-talk leading to cell death in endocrine and lapatinib-resistant HER2+/ER+ breast cancer cellsSonja Thaler, Marcus Schmidt, Sven Roβwag, et al.
Biotechniques|June 2, 2009
Cell cycle quiescence can suppress transcription from an ecdysone receptor-based inducible promoter in mammalian cellsSabine Wallbaum, Nicole Grau, Anja Schmid, et al.
Pageof 9